Biotronik Launches Lumax 540 Series Cardiac Rhythm Management Devices in U.S.


May 26, 2009

May 26, 2009 – Biotronik Inc. recently launched its Lumax 540 series implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillator (CRT-D) devices during Heart Rhythm 2009.

Combined with Biotronik Home Monitoring, the company’s wireless remote monitoring system for implantable-device patients, the Lumax 540 series enables continuous automatic data transmission of clinically relevant events. The information is available to physicians online, allowing them to monitor their patients’ cardiac and device status without patients having to visit the medical office.

“Lumax 540 has an excellent range of features that allows physicians to tailor pacing and ICD therapies to each patient’s individual needs,” said Charles Love, M.D., professor of medicine and director of cardiac rhythm device services at the Ohio State University Medical Center, Columbus, Ohio. “Coupled with the Biotronik Home Monitoring technologies, we are able to access patients’ clinical data, such as cardiac status, alert history, and clinical notes, online anywhere in the world. This makes for an excellent and comprehensive rhythm management solution.”

The Lumax 540 series offers a full suite of programming solutions for state-of-the-art tachycardia therapy management that allows the physician to optimize therapy based on patients’ dynamic needs.

The Lumax 540 series DFT Manager allows physicians to noninvasively manage high-DFT patients using programmable shock pathways, waveforms, and polarities. The company said these features are designed to ensure that life-saving shock therapy is delivered successfully. Additional advanced features, including RVsense Triggering and Negative AV Hysteresis, ensure effective resynchronization therapy for heart-failure patients.

Lumax 540 devices offer technology to help reduce the pain and anxiety resulting from unnecessary shocks.

For more information: